Saturday 17 October 2026
Export OPRX’s income statement to Excel — free account
OptimizeRx Corp.
OPRX Healthcare Health Information Services
OptimizeRx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $109.4 million, up 18.8% from fiscal 2024. In the quarter to June 2026, revenue fell 29.8%, EPS fell 150.0%, free cash flow grew 89.9% and total debt fell 33.1%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
8.50
0.35
−3.95%
Follow OPRX
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 529.95 | 0.00 | 0.00 | 2,736.12 | 0.00 | 0.00 | 0.00 | 45.41 |
Piotroski F-Score |
3 | 4 | 8 | 3 | 3 | 7 | 4 | 2 | 5 | 8 |
Altman Z-Score |
1.39 | 4.65 | 10.54 | 6.84 | 27.00 | 67.83 | 21.47 | 2.25 | 0.82 | 3.31 |
P/S ratio |
3.10 | 3.74 | 5.60 | 5.59 | 10.67 | 17.46 | 4.88 | 3.36 | 0.97 | 2.08 |
P/FCF ratio |
0.00 | 0.00 | 169.39 | 0.00 | 0.00 | 4,458.46 | 29.25 | 0.00 | 20.05 | 12.11 |
Altman Z″-Score (non-manufacturers) |
(2.99) | (6.22) | 2.06 | 4.07 | 5.39 | 18.48 | 18.15 | 1.53 | 1.48 | 3.37 |
Beneish M-Score |
(4.26) | (2.57) | (0.30) | (2.32) | (1.25) | (2.20) | (3.25) | (3.03) | (3.12) | (2.77) |
P/Operating CF |
(57.91) | 8,724.69 | 127.39 | (91.67) | (178.22) | (801.76) | 108.60 | (38.42) | 449.01 | 32.09 |
P/B ratio |
3.08 | 7.29 | 6.44 | 3.06 | 9.25 | 8.14 | 2.41 | 1.90 | 0.76 | 1.77 |
Price to Tangible BV |
3.42 | 8.34 | 12.48 | 8.50 | 19.99 | 10.10 | 3.37 | 0.00 | 145.03 | 13.68 |
EV/Sales |
2.20 | 3.32 | 5.18 | 4.85 | 10.44 | 16.08 | 3.69 | 3.67 | 1.18 | 2.10 |
EV/EBITDA |
0.00 | 0.00 | 221.34 | 0.00 | 0.00 | 423.69 | 0.00 | 0.00 | 0.00 | 13.41 |
EV/Operating CF |
(36.54) | (27.20) | 138.68 | (71.78) | (71.62) | 1,357.68 | 21.64 | (36.30) | 22.16 | 12.28 |
EV/FCF |
(20.88) | (23.34) | 156.69 | (36.70) | (56.96) | 4,106.99 | 22.15 | (33.01) | 24.43 | 12.24 |
Quick Ratio |
2.75 | 2.41 | 3.63 | 4.30 | 2.83 | 11.69 | 11.47 | 2.86 | 2.77 | 2.91 |
Current Ratio |
2.78 | 2.49 | 3.72 | 4.44 | 3.28 | 12.29 | 11.74 | 3.04 | 2.89 | 3.04 |
Net Debt/EBITDA |
5.23 | 2.84 | (17.95) | 7.26 | 61.32 | (36.26) | 7.20 | (0.94) | (2.28) | 0.13 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 1.00% | 0.74% | 0.23% | 0.17% | 19.76% | 19.17% | 14.51% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.29 | 0.28 | 0.20 |
Asset Turnover |
0.65 | 1.14 | 1.22 | 0.60 | 0.74 | 0.61 | 0.45 | 0.45 | 0.52 | 0.63 |
Operating CF/Net income |
0.30 | 0.70 | 3.50 | 0.53 | 2.86 | 1.92 | (0.93) | 0.41 | (0.24) | 3.65 |
Capex/Depreciation |
(1.49) | (0.13) | (0.29) | (1.35) | (0.06) | (0.25) | (0.12) | (0.33) | (0.09) | 0.01 |
Interest Coverage |
(37.39) | (82.24) | 3.90 | (12.82) | (31.13) | 21.24 | (14.42) | (18.16) | (2.22) | 2.21 |
| (18.37%) | (29.99%) | 1.83% | (9.93%) | (4.65%) | 0.42% | (8.88%) | (13.90%) | (16.51%) | 4.18% | |
| (12.94%) | (19.81%) | 1.30% | (7.69%) | (3.77%) | 0.38% | (8.30%) | (11.05%) | (11.34%) | 2.95% | |
ROIC |
(127.11%) | (121.25%) | 1.18% | (8.69%) | (3.34%) | 0.48% | (14.71%) | (11.08%) | (6.28%) | 5.60% |
Return on Tangible Assets |
(23.03%) | (38.73%) | 1.94% | (14.82%) | (9.60%) | 0.36% | (12.66%) | (48.00%) | (56.70%) | 11.78% |
Average Days of Receivables |
144.11 | 103.26 | 111.15 | 110.07 | 150.72 | 147.69 | 129.49 | 190.30 | 151.39 | 128.43 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
72.71% | 63.97% | 55.22% | 72.57% | 55.79% | 54.15% | 78.84% | 81.12% | 66.50% | 52.28% |
Intangible Assets out of Total Assets |
0.07 | 0.08 | 0.36 | 0.51 | 0.45 | 0.18 | 0.27 | 0.70 | 0.68 | 0.63 |
Share Based Compensation of Revenue |
7.22% | 7.44% | 11.89% | 9.19% | 7.33% | 8.96% | 25.21% | 19.18% | 12.45% | 6.36% |
Graham Net Nets |
0.27 | 0.12 | 0.08 | 0.11 | 0.05 | 0.10 | 0.30 | (0.01) | 0.00 | 0.07 |
Graham Number |
0.00 | 0.00 | 0.89 | 0.00 | 0.00 | 1.97 | 0.00 | 0.00 | 0.00 | 6.48 |
Earnings Yield |
(6.17%) | (4.55%) | 0.19% | (2.14%) | (0.48%) | 0.04% | (3.68%) | (7.19%) | (22.63%) | 2.20% |
Free Cash Flow Yield |
(3.39%) | (3.80%) | 0.59% | (2.36%) | (1.72%) | 0.02% | 3.42% | (3.31%) | 4.99% | 8.26% |
Revenue per Share |
0.78 | 1.24 | 1.96 | 1.84 | 2.92 | 3.56 | 3.51 | 4.18 | 5.04 | 5.90 |
Operating CF per Share |
(0.05) | (0.15) | 0.07 | (0.12) | (0.43) | 0.04 | 0.60 | (0.42) | 0.27 | 1.01 |
Capex per Share |
(0.04) | 0.00 | (0.01) | (0.12) | (0.01) | (0.03) | (0.01) | (0.05) | (0.02) | 0.00 |
Free Cash Flow per Share |
(0.08) | (0.15) | 0.06 | (0.24) | (0.43) | 0.01 | 0.59 | (0.47) | 0.24 | 1.01 |
Cash per Share |
0.71 | 0.52 | 0.82 | 1.41 | 0.71 | 4.92 | 4.17 | 0.81 | 0.73 | 1.26 |
Shareholders Equity per Share |
0.79 | 0.63 | 1.70 | 3.35 | 3.37 | 7.63 | 7.09 | 7.39 | 6.40 | 6.91 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.79 | 0.63 | 1.70 | 3.35 | 3.37 | 7.63 | 7.09 | 7.39 | 6.40 | 6.91 |
Free Cash Flow |
(0.82) | (1.52) | 0.70 | (3.25) | (6.44) | 0.24 | 10.41 | (8.10) | 4.44 | 18.78 |
Working Capital |
6.51 | 5.27 | 11.50 | 21.03 | 22.83 | 105.74 | 90.18 | 36.45 | 35.32 | 43.45 |
Capital Expenditures |
(0.35) | (0.04) | (0.09) | (1.59) | (0.12) | (0.49) | (0.25) | (0.86) | (0.45) | 0.07 |
Net Current Asset Value |
6.51 | 5.27 | 9.14 | 15.37 | 22.51 | 105.51 | 90.04 | (2.49) | (0.20) | 16.09 |
EV/EBIT |
0.00 | 0.00 | 609.96 | 0.00 | 0.00 | 2,729.65 | 0.00 | 0.00 | 0.00 | 19.65 |
Capex to Sales |
0.05 | 0.00 | 0.00 | 0.06 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 659.43 | 0.00 | 0.00 | 2,963.25 | 0.00 | 0.00 | 0.00 | 19.45 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.36 | 1.94 | 2.12 | 6.68 | 13.24 | 13.67 | 14.72 | 17.54 | 34.43 | 51.29 |
Cash ROIC |
(5.49%) | (13.42%) | 2.56% | (5.05%) | (10.56%) | 0.11% | 5.19% | (4.59%) | 2.72% | 10.59% |
Accounts Receivable Turnover |
2.62 | 3.74 | 4.29 | 3.55 | 3.42 | 2.87 | 2.66 | 2.41 | 2.44 | 2.85 |
Accounts Payable Turnover |
5.93 | 14.94 | 20.73 | 20.26 | 34.57 | 41.88 | 21.78 | 15.16 | 14.94 | 18.90 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
39.50 | 27.03 | 16.67 | 19.65 | 11.75 | 8.63 | 24.09 | 28.40 | 24.03 | 16.66 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
2.95 | 3.25 | 4.94 | 6.94 | 12.65 | 21.34 | 23.48 | 29.72 | 37.75 | 38.36 |
Average Payables |
0.58 | 0.41 | 0.43 | 0.45 | 0.56 | 0.61 | 1.08 | 1.89 | 2.19 | 1.90 |
Average Assets |
11.90 | 10.62 | 17.41 | 40.85 | 58.48 | 100.66 | 137.82 | 159.01 | 177.27 | 174.04 |
Average Common Equity |
8.38 | 7.02 | 12.34 | 31.66 | 47.42 | 90.68 | 128.75 | 126.33 | 121.78 | 122.65 |
Columns are period end dates